Brean Murray Initiating Coverage On Onyx Pharmaceuticals, Inc. (NASDAQ)
Brean Murray Carret & Co. is out with a research report on Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) and it is initiating coverage with a Hold rating.
Shares of ONXX closed at $33.69 yesterday, down 1 cent.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Brean Murray Carret & Co.Analyst Color Initiation Analyst Ratings